Cargando…
Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN‐HF Registry
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335571/ https://www.ncbi.nlm.nih.gov/pubmed/32122220 http://dx.doi.org/10.1161/JAHA.119.014512 |
Ejemplares similares
-
Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN‐HF Registry
por: MacDonald, Michael R., et al.
Publicado: (2019) -
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
por: Gronda, Edoardo, et al.
Publicado: (2020) -
Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction
Publicado: (2017) -
Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional Analysis
por: Vijay, Aishwarya, et al.
Publicado: (2023) -
Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry)
por: Jin, Xuejuan, et al.
Publicado: (2019)